General MedicationsORALGeneric
ALBAMYCIN
NOVOBIOCIN SODIUM
Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview ALBAMYCIN is listed in Drugs@FDA under application 050339 (NDA).
Marketing status: Discontinued Active ingredient NOVOBIOCIN SODIUM Form and strength CAPSULE; ORAL - EQ 250MG BASE Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1983-02-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ALBAMYCIN is listed in Drugs@FDA under application 050339 (NDA). Marketing status: Discontinued Active ingredient NOVOBIOCIN SODIUM Form and strength CAPSULE; ORAL - EQ 250MG BASE Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1983-02-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.